应《网络安全法》要求，自2017年10月1日起，未进行实名认证将不得使用互联网跟帖服务。为保障您的帐号能够正常使用，请尽快对帐号进行手机号验证，感谢您的理解与支持！

24小时热门版块排行榜    

小木虫论坛-学术科研互动平台 » 生物医药区 » 新药研发 » 质量控制 » 求助，大侠们，帮忙查一下USP35里面的celecoxib，着急啊谢谢
51/1返回列表
查看: 1430  |  回复: 4
只看楼主 @他人 存档 新回复提醒 (忽略) 收藏    在APP中查看

wangyi85

银虫 (初入文坛)

[求助] 求助，大侠们，帮忙查一下USP35里面的celecoxib，着急啊谢谢

我的邮箱是zkx0928@126.com，先谢谢啦
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐，对您同样有帮助:
1楼 2012-04-10 14:35:19
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

痴夷子皮

版主 (文坛精英)

老痞

优秀版主优秀版主

【答案】应助回帖

★ ★ ★
感谢参与，应助指数 +1
从头开始: 金币+3 2012-04-11 11:25:02
Add the following:
Celecoxib
(sel'' e kox' ib).

C17H14F3N3O2S 381.4
4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;     
p-[5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide     [169590-42-5].
DEFINITION
Celecoxib contains NLT 98.0% and NMT 102.0% of C17H14F3N3O2S, calculated on the anhydrous basis.
IDENTIFICATION
•  A. Infrared Absorption 197: [Note—Methods 197A, 197K, or 197M under Infrared Absorption may be used. ]
[Note—If the spectra obtained show differences, dissolve the substance to be examined and the Reference Standard separately in isopropyl alcohol, evaporate to dryness, and record the new spectra. ]
•  B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
ASSAY
•  Procedure
Buffer:  2.7 g/L of monobasic potassium phosphate adjusted with phosphoric acid to a pH of 3.0 ± 0.2
Mobile phase:  Methanol, acetonitrile, and Buffer (3:1:6)
Diluent:  Methanol and water (3:1)
System suitability solution:  0.5 mg/mL of USP Celecoxib RS and 2.4 µg/mL each of USP Celecoxib Related Compound A RS and USP Celecoxib Related Compound B RS in Diluent
Standard solution:  0.5 mg/mL of USP Celecoxib RS in Diluent
Sample solution:  0.5 mg/mL of Celecoxib in Diluent
Chromatographic system  
(See Chromatography 621, System Suitability.)
Mode:  LC
Detector:  UV 215 nm
Column:  4.6-mm × 25-cm; 5-µm packing L11
Column temperature:  60
Flow rate:  1.5 mL/min
Injection size:  25 µL
Run time:  About 1.5 times the celecoxib peak elution
System suitability  
Samples:  System suitability solution and Standard solution
Suitability requirements  
Resolution:  NLT 1.8 between celecoxib related compound A and celecoxib and NLT 1.8 between celecoxib and celecoxib related compound B, System suitability solution
Relative standard deviation:  NMT 0.73%, Standard solution
Analysis  
Samples:  Standard solution and Sample solution
Calculate the percentage of C17H14F3N3O2S in the portion of Celecoxib taken:
Result = (rU/rS) × (CS/CU) × 100
rU = = peak response from the Sample solution
rS = = peak response from the Standard solution
CS = = concentration of the Standard solution (mg/mL)
CU = = concentration of the Sample solution (mg/mL)

Acceptance criteria:  98.0%–102.0% on the anhydrous basis
IMPURITIES
Inorganic Impurities  
•  Heavy Metals: NMT 20 ppm
Diluent:  Acetone and water (17:3)
Standard solution:  Dilute 1.0 mL of Standard Lead Solution, prepared as directed under Heavy Metals 231, Special Reagents, with Diluent to 20 mL.
Sample solution:  Dissolve 0.50 g of Celecoxib in 20 mL of Diluent.
Blank solution:  20 mL of Diluent
Analysis  
Samples:  Standard solution, Blank solution, and Sample solution
To each solution, add 2 mL of pH 3.5 Acetate Buffer, prepared as directed under Heavy Metals 231, Method I. Mix, and add to each solution 1.2 mL of thioacetamide–glycerin base TS. Mix immediately, and allow to stand for 2 min. Pass the solutions through a filter of 0.45-µm pore size. Compare the spots on the filters obtained from each of the solutions.
Acceptance criteria:  The brownish-black color of the spot resulting from the Sample solution is not more intense than that of the spot resulting from the Standard solution. The test is invalid if the Standard solution does not show a brownish-black color compared to the Blank solution.
•  Residue on Ignition 281: NMT 0.2%, using a platinum crucible
Organic Impurities  
•  Procedure
Buffer, Mobile phase, Diluent, System suitability solution, Sample solution, and Chromatographic system:  Proceed as directed in the Assay.
Standard solution:  0.5 µg/mL of USP Celecoxib RS in Diluent
System suitability  
Samples:  System suitability solution and Standard solution
Suitability requirements  
Resolution:  NLT 1.8 between celecoxib related compound A and celecoxib and NLT 1.8 between celecoxib and celecoxib related compound B, System suitability solution
Signal-to-noise ratio:  NLT 20, Standard solution
Analysis  
Samples:  Standard solution and Sample solution
Calculate the percentage of each impurity in the portion of Celecoxib taken:
Result = (rU/rS) × (CS/CU) × 100
rU = = peak response for each impurity in the Sample solution
rS = = peak response of celecoxib in the Standard solution
CS = = concentration of celecoxib in the Standard solution (mg/mL)
CU = = concentration of Celecoxib in the Sample solution (mg/mL)
Acceptance criteria  
Individual impurities:  See Table 1. [Note—Disregard any impurity peak less than 0.05%. ]

SPECIFIC TESTS
•  Water Determination, Method I 921: NMT 0.5%, using a 400-mg sample
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve in tight containers, protected from light and moisture. Store at room temperature.
•  USP Reference Standards 11
USP Celecoxib RS  
p-[5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide.
    C17H14F3N3O2S         381.4
USP Celecoxib Related Compound A RS
4-[5-(3-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide.
    C17H14F3N3O2S        381.4
USP Celecoxib Related Compound B RS
4-[3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide.
    C17H14F3N3O2S        381.4
1S (USP35)
Auxiliary Information— Please check for your question in the FAQs before contacting USP.

USP35–NF30 Supplement : No. 1 Page 5447
Pharmacopeial Forum: Volume No. 36(6) Page 1519
赞一下 回复此楼

» 本帖已获得的红花（最新10朵）

wangyi85
守候在风中的宁静。
2楼2012-04-10 16:49:16
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

痴夷子皮

版主 (文坛精英)

老痞

优秀版主优秀版主

顺道广告一下。免费查询USP35，EP7.2
http://muchong.com/bbs/viewthread.php?tid=4342105&fpage=1
赞一下 回复此楼
守候在风中的宁静。
3楼2012-04-10 16:51:06
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

wangyi85

银虫 (初入文坛)
送鲜花一朵
引用回帖:
2楼: Originally posted by 痴夷子皮 at 2012-04-10 16:49:16:
Add the following:
Celecoxib
(sel'' e kox' ib).

C17H14F3N3O2S 381.4
4-benzenesulfonamide;     
p-benzenesulfonamide     .
DEFINITION
Celecoxib contains NLT 98.0% and NMT 102.0% of C17 ...

非常感谢！
回复此楼
4楼2012-04-11 10:59:10
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

liuxiaolu88

银虫 (初入文坛)
引用回帖:
2楼: Originally posted by 痴夷子皮 at 2012-04-10 16:49:16
Add the following:
Celecoxib
(sel'' e kox' ib).

C17H14F3N3O2S 381.4
4-benzenesulfonamide;     
p-benzenesulfonamide     .
DEFINITION
Celecoxib contains NLT 98.0% and NMT 102.0% of C17H1 ...

塞来昔布
celecoxib
谢谢痴夷子皮

我的邮箱是lulu-8385@163.com
赞一下 回复此楼
5楼2012-07-02 10:14:19
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 wangyi85 的主题更新
51/1返回列表
普通表情 龙 兔 虎 猫
信息提示
关闭
请填处理意见
关闭